Gene · 690
Papers2,843
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,843
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The protective activity of genistein against bone and cartilage diseases. | Front Pharmacol | 2022 | 36160403 | PubTator, text mining | PubMed |
| Cranial and Odontological Methods for Sex Estimation-A Scoping Review. | Medicina (Kaunas) | 2022 | 36143950 | PubTator, text mining | PubMed |
| Gallic Acid Ameliorates the Inflammatory State of Periodontal Ligament Stem Cells and Promotes Pro-Osteodifferentiation Capabilities of Inflammatory Stem Cell-Derived Exosomes. | Life (Basel) | 2022 | 36143428 | PubTator, text mining | PubMed |
| Optical Coherence Tomography Significance in Managing Early Onset of Optic Pathway Gliomas in Children Younger than 5 Years of Age-A Retrospective Study. | Children (Basel) | 2022 | 36138616 | PubTator, text mining | PubMed |
| Experimental Study on the Inhibition of RANKL-Induced Osteoclast Differentiation In Vitro by Metformin Hydrochloride. | Int J Endocrinol | 2022 | 36132487 | PubTator, text mining | PubMed |
| Third-Generation Platelet Concentrates in Periodontal Regeneration: Gaining Ground in the Field of Regeneration. | Cureus | 2022 | 36127983 | PubTator, text mining | PubMed |
| MiR-137-mediated negative relationship between LGR4 and RANKL modulated osteogenic differentiation of human adipose-derived mesenchymal stem cells. | Genet Mol Biol | 2022 | 36121915 | PubTator, text mining | PubMed |
| Multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS. | PLoS Pathog | 2022 | 36121875 | PubTator, text mining | PubMed |
| Current update on the visual outcome of optic pathway glioma associated with neurofibromatosis type-1. | Front Surg | 2022 | 36117804 | PubTator, text mining | PubMed |
| Update Breast Cancer 2022 Part 3 - Early-Stage Breast Cancer. | Geburtshilfe Frauenheilkd | 2022 | 36110894 | PubTator, text mining | PubMed |
| A Case Report on Surgical-Orthodontic Correction of Skeletal Class III Malocclusion with Severe Prognathic Mandible and Retrognathic Maxilla. | J Pharm Bioallied Sci | 2022 | 36110821 | PubTator, text mining | PubMed |
| A Novel Minimal Access Technique for Removal of Impacted Third Molars using Lasers - SMAL Technique. | J Pharm Bioallied Sci | 2022 | 36110796 | PubTator, text mining | PubMed |
| Influence and Impact of Mandibular Ramal Dimensions on the Incidence of Lower Third Molar Impaction: A Prospective Study. | J Pharm Bioallied Sci | 2022 | 36110757 | PubTator, text mining | PubMed |
| The Role of Prp in Third Molar Extraction Wounds: A Clinical Study. | J Pharm Bioallied Sci | 2022 | 36110662 | PubTator, text mining | PubMed |
| Surgical Management and Prosthetic Rehabilitation of Dentigerous Cyst Associated with Impacted Mandibular Canine: A Case Report. | J Pharm Bioallied Sci | 2022 | 36110612 | PubTator, text mining | PubMed |
| Interferon-gamma modulates articular chondrocyte and osteoblast metabolism through protein kinase R-independent and dependent mechanisms. | Biochem Biophys Rep | 2022 | 36105611 | PubTator, text mining | PubMed |
| Experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized rats. | Heliyon | 2022 | 36105473 | PubTator, text mining | PubMed |
| Traditional Chinese medicine paraffin therapy: an evidence-based overview from a modern medicine perspective. | Chin Med | 2022 | 36104753 | PubTator, text mining | PubMed |
| Severity and Treatment Difficulty of Impacted Maxillary Canine among Orthodontic Patients in Riyadh, Saudi Arabia. | Int J Environ Res Public Health | 2022 | 36078396 | PubTator, text mining | PubMed |
| The association between dietary vitamin C intake and periodontitis: result from the NHANES (2009-2014). | BMC Oral Health | 2022 | 36076176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/690/papers?page=42